NHS investment in cannabis-based research
Medical cannabis was legalised in the UK in 2018 following high-profile campaigns by patients and advocates, primarily concerning the use of cannabis-based medicines in the treatment of refractory epilepsy. Over six years on, only a handful of patients have received an NHS prescription for medical cannabis. But could the completion of long-awaited NHS-backed medical cannabis clinical trials help improve access to these medicines in the future?